Peak health my heart
Release time:
2020-08-14
Peak Health My heart goes to
. I especially like a word-efforts will never be in vain. The seeds sown today are quietly taking root somewhere you can't see or think. When I was young, I often imagined what I would do in the future, what would happen in the future, and I kept working hard for my dreams.
My family is in the countryside. Since I was a child, my family's conditions are very bad. I often can't afford to pay tuition fees. When I go to school, I want to graduate quickly, go to work quickly to make money, and lighten the burden on my family. When I graduated, I was assigned to Shangyu Pharmaceutical Factory and worked in the workshop. My parents felt that this job was relatively stable and very good for girls, but when I was young, I didn't like too rigid and mechanical work, so I didn't listen to my parents' opinions and chose the health care industry that was not favored by my family at that time. For this reason, my parents are very angry and disappointed with me.
Since entering the health care industry, it has been eight years since I insisted on it. In these eight years, I have gained a lot of valuable experience and material gains along the way from the grass-roots marketing staff to the regional manager, from the head of the appreciation service department to the front-line lecturer. During my nearly one year as a lecturer, I have had the opportunity to participate in the product promotion of Jianfeng Healthy Grape Seed Extract Soft Capsule and Gutai Capsule, and naturally have a better understanding of Jianfeng Group, especially Jianfeng Health Technology Co., Ltd. Through the feedback from customers in the process of product promotion, I was deeply impressed by the products, culture and business philosophy of Jianfeng Health. I also had the opportunity to meet Jianfeng Health's friends and became a new employee of this enterprise by chance.
Before, I always heard about the various drawbacks of state-owned enterprise management. Before, I also worried about whether it would be difficult to adapt. But after more than ten days of class, I felt quite a lot. The marketing team of Jianfeng Health is a team with love, unity and progress. The professionalism of the team, the formality of the enterprise and the development process of Jianfeng all make me admire. The achievements of generations of Jianfeng people have deeply attracted me. In my thirties, I am very grateful to the peak for giving me this development platform. Now I can proudly say to the people around me: I work in the peak, I am the peak person! (Yang Ting thinks)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page